The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled.
Category Archives: Food Safety News
FDA approves Xermelo for carcinoid syndrome diarrhea
The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled.
Whole Foods Market recalls “Our Chefs’ Own” Spinach Orzo Salad due to undeclared tree nut allergen
Whole Foods Market® is recalling “Our Chefs’ Own” Spinach Orzo Salad sold in stores in Massachusetts, Connecticut, New Hampshire, Maine and Rhode Island due to an undeclared tree nut allergen. Only Spinach Orzo Salad with PLU 61159 and a “sold on” date of February 24 or before is included in this recall. The effected salad was sold from the chef cases or in prepackaged containers.
Read The Complete Story!
Whole Foods Market recalls “Our Chefs’ Own” Spinach Orzo Salad due to undeclared tree nut allergen
Whole Foods Market® is recalling “Our Chefs’ Own” Spinach Orzo Salad sold in stores in Massachusetts, Connecticut, New Hampshire, Maine and Rhode Island due to an undeclared tree nut allergen. Only Spinach Orzo Salad with PLU 61159 and a “sold on” date of February 24 or before is included in this recall. The effected salad was sold from the chef cases or in prepackaged containers.
Read The Complete Story!
Manzana Products Co., Inc. Issues Voluntary Recall of Apple Sauces Due to Potential Presence of Foreign Material
Manzana Products Co., Inc. is voluntarily recalling three different types of Trader Joe’s Unsweetened Apple Sauces due to the potential presence of glass pieces.
Read The Complete Story!
Manzana Products Co., Inc. Issues Voluntary Recall of Apple Sauces Due to Potential Presence of Foreign Material
Manzana Products Co., Inc. is voluntarily recalling three different types of Trader Joe’s Unsweetened Apple Sauces due to the potential presence of glass pieces.
Read The Complete Story!
FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis
The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use procalcitonin (PCT), a protein associated with the body’s response to a bacterial infection, as a biomarker to help make antibiotic management decisions in patients with these conditions.
FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis
The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use procalcitonin (PCT), a protein associated with the body’s response to a bacterial infection, as a biomarker to help make antibiotic management decisions in patients with these conditions.
FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis
The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use procalcitonin (PCT), a protein associated with the body’s response to a bacterial infection, as a biomarker to help make antibiotic management decisions in patients with these conditions.
FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results
The U.S. Food and Drug Administration today allowed marketing of the PhenoTest BC Kit, performed on the Pheno System. This is the first test to identify organisms that cause bloodstream infections and provide information about which antibiotics the organism is likely to respond to (antibiotic sensitivity).